Clinical trials
Phase 2 Plaque, Amyloid trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Lantheus Biosciences Ltd. | 2 |
| Novartis Pharmaceuticals | 2 |
| Brigham and Women's Hospital | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Emory University | 1 |
| Galimedix Therapeutics Inc | 1 |
| IDEAYA Biosciences | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Instituto Grifols, S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Plaque, Amyloid | 24 |
| Alzheimer Disease | 9 |
| Psoriasis | 6 |
| Lymphoma, Follicular | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Cognitive Dysfunction | 2 |
| Dementia | 2 |
| Pick Disease of the Brain | 2 |
| Skin Diseases | 2 |
| Brain Diseases | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.